MUMBAI, May 14 (Xinhua) -- India's Dr Reddy's Laboratories has launched the Russia's Sputnik COVID-19 vaccine on Friday by administering the first dose to a patient in the South Eastern city of Hyderabad, according to a corporate filing with the Bombay Stock Exchange. The vaccine is pric...
COVID-19 cases in Indian states 2023, by type Medical Technology Cumulative vaccine doses administered for COVID-19 India 2021-2023 Further recommended statistics Global overview Numbers in India State figures Second wave Public opinionKey insights Number of confirmed cases as of March 30, 2023...
An effective vaccine against COVID-19 is need of the hour. India has been a hub for vaccine productions and Indian pharmaceutical companies have contributed immensely to the vaccine related projects running all over the world. Indian companies have also been pioneers in starting working on COVID-...
To date,India has administeredaround 160 million doses of a coronavirus vaccine (the predominant shots being used are theAstraZenecashot, produced locally as Covishield, as well as an indigenous vaccine called Covaxin developed by Bharat Biotech). In April it approved Russia’s Sputnik V vaccine...
In October 2021, Russia's Health Ministry allowed early trials of a nasal form of Sputnik V among 500 volunteers, but the status of those trials and the availability of the vaccine remains unclear. Vaccination rates in India have dipped in the past months with detected cases plateauin...
So far, no vaccine has been approved for commercial use against COVID-19. The number of COVID-19 cases in India Friday reached 625,544 and the death toll rose to 18,213. Enditem
NEW DELHI, Nov. 3 (Xinhua) -- India-made COVID-19 vaccine Covaxin, developed by the biotechnology company Bharat Biotech, on Wednesday was approved by the World Health Organization (WHO) for emergency use. According to an India Today report, the WHO's technical advisory group has recommended...
A health worker pretends to inject the COVID-19 vaccine to a woman during a mock drill for COVID-19 vaccination at a vaccination centre in New Delhi, India, Jan. 2, 2021. (Xinhua/Partha Sarkar) The objective of the dry run is to assess the operational feasibility of the use of Co-...
So far at least 350 million of India's 1.34 billion have had at least a first dose of COVID-19 vaccine. The nationwide vaccination program has picked up pace following a devastating second wave of coronavirus infections in April and May, which crippled the country's health care services and...
COVID-19. Two tests of blood serum from persons who had received COVAXIN suggest that the vaccine creates antibodies that efficiently neutralize the SARS-CoV-2 B.1.1.7 (Alpha) and B.1.617 (Delta) variants(1)and(2), which were originally identified in the United Kingdom and India, ...